What's Happening?
U.S. Senators Ted Budd (R-N.C.) and Lisa Blunt Rochester (D-Del.) have introduced the Standards and Collaboration for American Leadership in Engineering (SCALE) Biology Act. This legislation aims to establish a Biometrology Laboratory Program under the National
Institute of Standards and Technology (NIST). The program will focus on research into engineering biology, biomanufacturing, and biotechnology, with the goal of advancing the measurement of key units and inputs in these fields. The bill seeks to promote U.S. competitiveness in biotech development. Representatives April McClain Delaney (D-Md.-06) and Jay Obernolte (R-Calif.-08) introduced companion legislation in the House of Representatives in May. The SCALE Biology Act has garnered endorsements from major technology companies, including OpenAI and Google.
Why It's Important?
The SCALE Biology Act is crucial for maintaining U.S. leadership in biotechnology innovation, which has significant implications for the American economy and national security. By establishing a Biometrology Laboratory Program, the U.S. aims to develop and standardize the fundamental inputs for biotechnology, ensuring that American standards remain the international benchmark. This initiative is particularly important given China's aggressive expansion in its bioeconomy, including a substantial increase in state support and research and development activities, and the rapid growth of biotech science parks. The bill seeks to counter these efforts by strengthening U.S. measurement science and technical standards, thereby accelerating innovation and facilitating the transition of new biotechnology from research to commercial application. This will benefit industries ranging from healthcare to agriculture and ensure a safe, secure, resilient, and trustworthy bioeconomy.
What's Next?
The SCALE Biology Act will proceed through the legislative process in both the Senate and the House of Representatives. If passed, NIST will be directed to collaborate with various governmental agencies, non-governmental organizations, industry, and academic institutions to develop standards for biomanufacturing and engineering biology. Additionally, the Director of NIST will be tasked with supporting the development of engineering biology foundries to enhance measurement assurance and make the engineering of living measurement systems more predictable. The endorsements from companies like OpenAI and Google suggest potential industry support for the bill's objectives, which could influence its passage and implementation. The program's success will be measured by its ability to solidify U.S. leadership in the global bioeconomy amidst increasing international competition.
Beyond the Headlines
The SCALE Biology Act addresses a deeper strategic imperative: the global race for technological dominance in critical emerging fields. Beyond immediate economic benefits, the legislation aims to safeguard national security by ensuring that the U.S. controls the foundational standards and research in biotechnology. This proactive approach is designed to prevent reliance on foreign standards and technologies, particularly from nations like China, which are heavily investing in their bioeconomy. The bill also highlights the growing convergence of biology and engineering, positioning biotechnology as a general-purpose technology with broad applications. The emphasis on measurement science and standardization underscores the importance of foundational research in driving innovation and commercialization, ultimately shaping the future landscape of scientific and industrial capabilities.
